Skip to main content

Advertisement

SpringerLink
Log in

Patch Testing Pearls

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Dermatitis is one of the most common illnesses encountered by healthcare providers and the causes are numerous. Contact dermatitis is the form of dermatitis resulting from contact with the environment, and it may be either irritant or allergic in nature. Patch testing has been the gold standard for diagnosis of allergic contact dermatitis since its formal description over 100 years ago by Jadassohn. While this diagnostic tool may seem simple to us today, there are numerous potential points for error that the practitioner must keep in mind. Patient selection, technique of patch test placement, allergen selection, patch test reading and interpretation, and patient management all must be considered. To simply apply a given set of test allergens indiscriminately and not be prepared to interpret the results accurately with patient education and management in mind would be a great failure. Conversely, with experience and the proper knowledge base some of the most complex dermatitis questions can be answered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kadyk DL, McCarter K, Achen F, Belsito DV (2003) Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol. 49(6):1037–1048

    Article  PubMed  Google Scholar 

  2. Thomson KF, Wilkinson SM, Sommer S, Pollock B (2002) Eczema: quality of life by body site and the effect of patch testing. Br J Dermatol. 146(4):627–630

    Article  CAS  PubMed  Google Scholar 

  3. Anderson RT, Rajagopalan R (2001) Effects of allergic dermatosis on health-related quality of life. Curr Allergy Asthma Rep. 1(4):309–315

    Article  CAS  PubMed  Google Scholar 

  4. Hutchings CV, Shum KW, Gawkroder DJ (2001) Occupational contact dermatitis has an appreciable impact on quality of life. Contact Dermatitis. 45(1):17–20

    Article  CAS  PubMed  Google Scholar 

  5. Rietschel RL (1995) Human and economic impact of allergic contact dermatitis and the role of patch testing. J Am Acad Dermatol. 33(5):812–815

    Article  CAS  PubMed  Google Scholar 

  6. Sulzberger MB, Wise F (1931) The contact or patch test in dermatology. Arch Dermatology Syphilol 23:519–531

    Article  Google Scholar 

  7. Smith SM, Nedorost ST (2010) Dermatitis defined. Dermatitis 21(5):248–250

    Article  PubMed  Google Scholar 

  8. Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M, Cannavó A, Giménez-Arnau A, Gonçalo M, Goossens A, John SM, Lidén C, Lindberg M, Mahler V, Matura M, Rustemeyer T, Serup J, Spiewak R, Thyssen JP, Vigan M, White IR, Wilkinson M, Uter W (2015) European Society of Contact Dermatitis guideline for diagnostic patch testing – recommendations on best practice. Contact Dermatitis 73:195–221

    Article  PubMed  Google Scholar 

  9. Meding B, Jarvholm B (2002) Hand eczema in Swedish adults –changes in prevalence between 1983 and 1996. J Invest Dermatol 118:719–723

    Article  CAS  PubMed  Google Scholar 

  10. Coenraads PJ, van Coevorden AM, Diepgen TL (2003) Hand eczema. In: Williams HC, Bigby M, Diepgen TL, Herxheimer A, Naldi L, Rzany B (eds) Evidence-based Dermatology. BMJ Books, London, pp 132–143

    Google Scholar 

  11. Diepgen TL (2003) Occupational skin-disease data in Europe. Int Arch Occup Environ Health 76:331–338

    Article  PubMed  Google Scholar 

  12. Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, McFadden J, Coenraads PJ (2007) Management of chronic hand eczema. Contact Dermatitis. 57(4):203–2010

    Article  PubMed  Google Scholar 

  13. Handa S, Kaur I, Gupta T, Jindal R (2012) Hand eczema: correlation of morphologic patterns, atopy, contact sensitization and disease severity. Indian. J Dermatol, Venereol Leprol 78(2):153–158

    Article  Google Scholar 

  14. Rietschel RL (1999) Atlas of contact dermatitis. Martin Dunitz, London

    Google Scholar 

  15. Huynh M, Sheehan M, Chung M, Zirwas M, Feldman S (2013) Regional Atlas of Contact Dermatitis: Extremities. Dermatol. 21(6):1–2

    Google Scholar 

  16. Sheehan M, Huynh M, Chung M, Zirwas M, Feldman S (2013) Regional Atlas of Contact Dermatitis: Mouth, Lips, and Perioral Region. Dermatol. 21(5):1–3

    Google Scholar 

  17. Huynh M, Sheehan M, Chung M, Zirwas M, Feldman S (2013) Regional Atlas of Contact Dermatitis: Anogenital. Dermatol. 21(4):1–3

    Google Scholar 

  18. Huynh M, Sheehan M, Chung M, Zirwas M, Feldman S (2013) Regional Atlas of Contact Dermatitis: Feet. Dermatol 21(2):1–2

    Google Scholar 

  19. Sheehan M, Huynh M, Chung M, Zirwas M, Feldman S (2013) Regional Atlas of Contact Dermatitis: Hands. Dermatol 21(1):1–3

    Google Scholar 

  20. Huynh M, Sheehan M, Chung M, Zirwas M, Feldman S (2012) Regional Atlas of Contact Dermatitis: Neck. Dermatol. 20(11):1–2

    Google Scholar 

  21. Huynh M, Sheehan M, Chung M, Zirwas M, Feldman S (2012) Regional Atlas of Contact Dermatitis: Eyelids. Dermatol. 20(10):1–2

    Google Scholar 

  22. Breit R (1977) Allergen change in stasis dermatitis. Contact Dermat 3:309

    Article  Google Scholar 

  23. Coenradds PJ, Bleumink E, Nater JP (1975) Susceptibility to primary irritants: age dependence and relation to contact allergic reactions. Contact Dermat 1:377

    Article  Google Scholar 

  24. Warshaw EM, Raju SI, Fowler JF, Maibach HI, Belsito DV, Zug KA, Rietschel RL, Taylor JS, Mathias T, Fransway AF, DeLeo VA, Marks JG, Storrs FJ, Pratt MD, Sasseville D (2012) Positive patch test reactions in older individuals: Retrospective analysis from the North American Contact Dermatitis Group, 1994–2008. J Am Acad Dermatol. 66(2):229–240

    Article  PubMed  Google Scholar 

  25. Rudikoff, Donald, et al. (2014)“Chapter 1: The History of Eczema and Atopic Dermatitis.”. Atopic Dermatitis and Eczematous Disorders, CRC Press, pp. 11–24.

  26. Clemmensen KKB, Thomsen SF, Jemec GBE, Agner T (2014) Pattern of contact sensitization in patients with and without atopic dermatitis in a hospital-based clinical database. Contact Dermat. 71:75–81

    Article  Google Scholar 

  27. Jacob SE, McGowan M, Silverberg NB, Pelletier JL, Fonacier L, Mousdicas N, Powell D, Scheman A, Goldenberg A (2017) Pediatric contact dermatitis registry data on contact allergy in children with atopic dermatitis. JAMA Dermatol 153(8):765–770

    Article  PubMed  PubMed Central  Google Scholar 

  28. Magembe AJ, Davis MP, Richardson D (2007) The angry back associated with patch testing: are there any predictors? Dermatitis. 18(2):115–116

    Article  Google Scholar 

  29. Mitchell JC (1975) The angry back syndrome. Eczema creates eczema. Contact Dermat 1:193–194

    Article  CAS  Google Scholar 

  30. Durate I, Lazzarini R (2006) Excited skin syndrome associated with patch-test application technique. Dermatitis 17(3):161–162

    Article  Google Scholar 

  31. Duarte I, Lazzarini R, Buense R (2002) Interference of the position of the substances present in an epicutaneous patch test series with occurrence of false-positive results. Am J Contact Dermat 13:125–132

    PubMed  Google Scholar 

  32. Joy NM, Rice KR, Atwater AR (2013) Stability of patch test allergens. Dermatitis 24(5):227–236

    Article  CAS  PubMed  Google Scholar 

  33. Hoeck UL. (2005) More T.R.U.E Test allergens are needed. J Am Acad Dermatol 52.

  34. Belsito DV et al (2004) Patch testing with a standard allergen ("screening") tray: rewards and risks. Dermatol Ther. 17(3):231–239

    Article  PubMed  Google Scholar 

  35. Nettis E et al (2003) Results of standard series patch testing in patients with occupational allergic contact dermatitis. Allergy. 58(12):1304–1307

    Article  CAS  PubMed  Google Scholar 

  36. Saripalli YV et al (2003) The detection of clinically relevant contact allergens using a standard screening tray of twenty-three allergens. J Am Acad Dermatol. 49(1):65–69

    Article  PubMed  Google Scholar 

  37. Suneja T et al (2001) Comparative study of Finn Chambers and T.R.U.E test methodologies in detecting the relevant allergens inducing contact dermatitis. J Am Acad Dermatol 45(6 pt 1):836–839

    Article  CAS  PubMed  Google Scholar 

  38. Katsarma G et al (1999) Suspected fragrance allergy requires extended patch testing to individual fragrance allergens. Contact Dermatitis. 41(4):193–197

    Article  CAS  PubMed  Google Scholar 

  39. Larkin A et al (1998) The utility of patch tests using larger screening series of allergens. Am J Contact Dermat. 9(3):142–145

    CAS  PubMed  Google Scholar 

  40. Cohen DE et al (1997) Utility of standard allergen series alone in the evaluation of allergic contact dermatitis: a retrospective study of 732 patients. J Am Acad Dermatol. 36(6 pt 1):914–918

    Article  CAS  PubMed  Google Scholar 

  41. Cronin E (1972) Clinical prediction of patch test results. Trans St Johns Hosp Dermatol Soc. 58:153–162

    CAS  PubMed  Google Scholar 

  42. Podmore P, Burrows D, Bingham EA (1984) Prediction of patch test results. Contact Dermat. 11:283–284

    Article  CAS  Google Scholar 

  43. Bruynzeel DP, Andersen KE, CamarasaJ G, Lachapelle JM, Menné T, White IR (1995) The European standard series. European Environmental and Contact Dermatitis Research Group (EECDRG). Contact Dermat 33:145–148

    Article  CAS  Google Scholar 

  44. Bruze M, Condé-Salazar L, Goossens A, Kanerva L, White IR (1999) Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis. Contact Dermat 41:241–250

    Article  CAS  Google Scholar 

  45. Warshaw EM, Belsito DV, DeLeo VA et al (2008) North American Contact Dermatitis Group patch-test results, 2003–2004 study period. Dermatitis. 19(3):129–136

    Article  PubMed  Google Scholar 

  46. Zug KA, Warshaw EM, Fowler JF Jr et al (2009) Patch-test results of the North American Contact Dermatitis Group 2005–2006. Dermatitis 20:149–160

    Article  CAS  PubMed  Google Scholar 

  47. Anveden I, Lindberg M, Andersen KE et al (2004) Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermat 50:298

    Article  CAS  Google Scholar 

  48. Fischer AA et al (2008) Fishers contact dermatitis. BC Decker Inc, Hamilton

    Google Scholar 

  49. Sukanto H et al (1981) Influence of topically applied corticosteroids on patch test reactions. Contact Dermat 7:180

    Article  CAS  Google Scholar 

  50. Clark RA, Rietschel RL (1982) 0.1% triamcinolone acetonide ointment and patch test responses. Arch Dermatol 118:163

    Article  CAS  PubMed  Google Scholar 

  51. Macfarlane AW, Curley RK, Graham RM, Lewis-Jones M, King CM (1989) Delayed patch test reactions at days 7 and 9. Contact Dermat 20:127–132

    Article  CAS  Google Scholar 

  52. Jonker MJ, Bruynzeel DP (2000) The outcome of an additional patch-test reading on days 6 or 7. Contact Dermat 42:330–335

    Article  CAS  Google Scholar 

  53. Isaksson M, Andersen KE, Brandão FM et al (2000) Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG. Contact Dermat 42:27–35

    Article  CAS  Google Scholar 

  54. Chaudhry HM, Drage LA, El-Azhary RA, Hall MR, Killian JM, Prakash AV, Yiannias JA, Davis MD (2017) Delayed patch-test reading after 5 days: An update from the Mayo Clinic Contact Dermatitis Group. Dermatitis 28(4):253–260

    Article  PubMed  Google Scholar 

  55. Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009) Allergic and irritant contact dermatitis. Eur J Dermatol 19:325–332

    CAS  PubMed  Google Scholar 

  56. Isaksson M, Bruze M (2005) Corticosteroids. Dermatitis 16(1):3–5

    PubMed  Google Scholar 

  57. Bruze M (1990) What is a relevant contact allergy? Contact Dermat 23:224–225

    Article  CAS  Google Scholar 

  58. Jacob SE, Brod B, Crawford GH (2008) Clinically relevant patch test reactions in children--a United States based study. Pediatr Dermatol. 25(5):520

    Article  PubMed  Google Scholar 

  59. Gipson KA, Carlson SW, Nedorost ST (2010) Physician-patient agreement in the assessment of allergen relevance. Dermatitis 21(5):275–279

    Article  PubMed  Google Scholar 

  60. Carlson S, Gipson K, Nedorost S (2010) Relevance of doubtful (“equivocal”) late patch-test readings. Dermatitis 21(2):102–108

    Article  PubMed  Google Scholar 

  61. Tamaka K, Seike M, Hagiwara T, Sato A, Ohtsu H (2015) Histamine suppresses regulatory T cells mediated by TGF-beta in murine chronic allergic contact dermatitis. Exp Dermatol 24(4):280–284

    Article  CAS  PubMed  Google Scholar 

  62. Ashida Y, Denda M, Hirao T (2001) Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Investig Dermatol 116(2):261–265

    Article  CAS  PubMed  Google Scholar 

  63. Wollenberg A, Sidhu MK, Odeyemi I et al (2008) Economic evaluation of maintenance treatment with tacrolimus 0.1% ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol. 159(6):1322–1330

    Article  CAS  PubMed  Google Scholar 

  64. Wollenberg A, Reitamo S, Atzori F et al (2008) Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 63(6):742–750

    Article  CAS  PubMed  Google Scholar 

  65. Lauerma AI, Stein BD, Homey B et al (1994) Topical FK 506: suppression of allergic and irritant contact dermatitis in the guine pig. Arch Dermatol Res 286:337

    Article  CAS  PubMed  Google Scholar 

  66. Pereira U, Boulais N, Lebonvallet N, Pennec JP, Dorange G, Misery L (2010) Mechanisms of the sensory effects of tacrolimus on the skin. Br J Dermatol. 163(1):70–77

    CAS  PubMed  Google Scholar 

  67. Schram ME, Roekevisch E, Leeflang MM et al (2011) A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 128:353–359

    Article  CAS  PubMed  Google Scholar 

  68. Egan CA, Rallis TM, Meadows KP et al (1999) Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol. 40:612–614

    Article  CAS  PubMed  Google Scholar 

  69. Denby KS, Beck LA (2012) Update on systemic therapies for atopic dermatitis. Curr Opin Allergy Clin Immunol. 12(4):421–426

    Article  CAS  PubMed  Google Scholar 

  70. Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J (2014) Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol. 133(2):429–438

    Article  CAS  PubMed  Google Scholar 

  71. Granlund H, Erkko P, Reitamo S (1998) Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol 78:40

    Article  CAS  PubMed  Google Scholar 

  72. Lakshmi C, Srinivas CR, Jayaraman A (2008) Ciclosporin in parthenium dermatitits-a report of 2 cases. Contact Dermatitis. 59(4):245–248

    Article  PubMed  Google Scholar 

  73. Munro CS, Levell NJ, Shuster S, Friedmann PS (1994) Maintenance treatment with cyclosporin in atopic eczema. Br J Dermatol 130:376–380

    Article  CAS  PubMed  Google Scholar 

  74. Sowden JM, Berth-Jones J, Ross JS, Motley RJ, Marks R, Finlay AY et al (1991) Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet 338:137–140

    Article  CAS  PubMed  Google Scholar 

  75. Griffiths CEM, Dubertret L (2004) Ellis CN, et al. cyclosporine in psoriasis clinical practice: an international consensus statement. Br J Dermatol 150:11–23

    Article  CAS  PubMed  Google Scholar 

  76. Wakelin, Sarah H.., et al. (2015) Handbook of systemic drug treatment in dermatology. CRC Press, Taylor & Francis, .

  77. Waxweiler WT, Agans R, Morrell DS (2011) Systemic treatment of pediatric atopic dermatitis with azathioprine and mycophenolate mofetil. Pediatr Dermatol 28(6):689–694

    Article  PubMed  Google Scholar 

  78. Prussick L, Plotnikova N, Gottlieb A (2016) Mycophenolate mofetil in severe atopic dermatitis. J Drugs Dermatol 15(6):715–718

    CAS  PubMed  Google Scholar 

  79. Samrao A, Berry TM, Goreshi R, Simpson EL (2012) A pilot study of an oral phosphodiesterase inhibitor (apremilast) for atopic dermatitis in adults. Arch Dermatol 148(8):890–897

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Abrouk M et al (2017) Apremilast treatment of atopic dermatitis and other chronic eczematous dermatoses. J Am Acad Dermatol 77(1):177–180

    Article  PubMed  Google Scholar 

  81. Simpson EL et al (2016) Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis. J Am AcadDermatol 75(3):506–515

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dermatology Physicians, Inc., 360 Plaza Drive Suite C, Columbus, IN, 47201, USA

    Betty A. Uyesugi & Michael P. Sheehan MD

  2. Indianapolis College of Osteopathic Medicine, Marian University, Indianapolis, USA

    Betty A. Uyesugi & Michael P. Sheehan MD

  3. School of Medicine Department of Dermatology, Indiana University, Bloomington, USA

    Michael P. Sheehan MD

Authors
  1. Betty A. Uyesugi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael P. Sheehan MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. Sheehan MD.

Ethics declarations

Disclosure

The authors have no relevant disclosures.

Human and Animal Rights

No research involving human participants and/or animals was used.

Informed Consent

No identifying patient information was used requiring informed consent.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Uyesugi, B.A., Sheehan, M.P. Patch Testing Pearls. Clinic Rev Allerg Immunol 56, 110–118 (2019). https://doi.org/10.1007/s12016-018-8715-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-018-8715-y

Keywords

Search

Navigation